Phenylketonuria Treatment

Phenylketonuria Treatment Market by Route of Administration (Oral, Parenteral), Product (Dietary Supplement, Drugs), Distribution - Global Forecast 2024-2030

SKU
MRR-030EE485160A
Region
Global
Publication Date
March 2024
Delivery
Immediate
2023
USD 742.34 million
2030
USD 1,781.82 million
2024
USD 840.56 million
CAGR
13.32%
360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the phenylketonuria treatment market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[186 Pages Report] The Phenylketonuria Treatment Market size was estimated at USD 742.34 million in 2023 and expected to reach USD 840.56 million in 2024, at a CAGR 13.32% to reach USD 1,781.82 million by 2030.

Phenylketonuria Treatment Market
To learn more about this report, request a free PDF copy
Phenylketonuria (PKU) is a rare genetic disorder characterized by the body's inability to metabolize the amino acid phenylalanine, resulting in its accumulation in the blood, and potentially resulting in brain damage and intellectual disability. Treatment for PKU focuses primarily on managing phenylalanine levels through dietary restrictions and specialized medical formulas. Additionally, enzyme replacement therapy and other medications can help reduce phenylalanine levels. The primary drivers include the unmet medical need for effective therapies and the rising awareness of early diagnosis due to the development of screening programs. Furthermore, the development of novel therapeutic drugs and dietary supplements for managing PKU symptoms is another significant driver. However, high treatment costs and limited availability of treatment options in certain regions are notable challenges. Additionally, the complexity of adhering to a strict lifelong diet can be a challenging factor. Improving medical dietary products with better taste and convenience is also needed to enhance patient compliance. Other hurdles include continuous monitoring and long-term management of the condition. Significant opportunities include the ongoing research into gene therapy, which could offer a potential cure for PKU. Advancements in drug delivery systems and the potential introduction of new therapeutic alternatives present considerable prospects.
Phenylketonuria Treatment Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Phenylketonuria Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Phenylketonuria Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Phenylketonuria Treatment Market, highlighting leading vendors and their innovative profiles. These include Ajinomoto Cambrooke, Inc., American Gene Technologies International Inc., BioMarin Pharmaceutical Inc., BioMarin Pharmaceuticals, Inc., Codexis, Inc., Daiichi Sankyo Company, Limited, ERYTECH Pharma S.A., Homology Medicines, Inc., Nutricia by Danone, PTC Therapeutics, Reckitt Benckiser Group PLC, Rubius Therapeutics, Inc., Synlogic, Inc., Ultragenyx Pharmaceutical, and Ultragenyx Pharmaceutical Inc..

Market Segmentation & Coverage

This research report categorizes the Phenylketonuria Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Route of Administration
    • Oral
    • Parenteral
  • Product
    • Dietary Supplement
    • Drugs
      • Biopten
      • Kuvan
  • Distribution
    • Drug Stores
    • Hospital Pharmacies
    • Online Pharmacies
    • Pediatric Clinics

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Phenylketonuria Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Phenylketonuria Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Phenylketonuria Treatment Market?
  4. What is the market share of the leading vendors in the Phenylketonuria Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Phenylketonuria Treatment Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Phenylketonuria Treatment Market, by Route of Administration
  7. Phenylketonuria Treatment Market, by Product
  8. Phenylketonuria Treatment Market, by Distribution
  9. Americas Phenylketonuria Treatment Market
  10. Asia-Pacific Phenylketonuria Treatment Market
  11. Europe, Middle East & Africa Phenylketonuria Treatment Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 372]
  16. List of Companies Mentioned [Total: 15]
Frequently Asked Questions
  1. How big is the Phenylketonuria Treatment Market?
    Ans. The Global Phenylketonuria Treatment Market size was estimated at USD 742.34 million in 2023 and expected to reach USD 840.56 million in 2024.
  2. What is the Phenylketonuria Treatment Market growth?
    Ans. The Global Phenylketonuria Treatment Market to grow USD 1,781.82 million by 2030, at a CAGR of 13.32%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.